2. Immunology/Inflammation
  3. NOD-like Receptor (NLR)
  4. NLRP3-IN-12

NLRP3-IN-12 是一种特异性的 NLRP3 炎症小体抑制剂。NLRP3-IN-12 通过靶向 NLRP3 蛋白抑制 IL-1β 的释放，IC50 值为 0.45 μM。NLRP3-IN-12 可用于研究炎症性肠病。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

NLRP3-IN-12 Chemical Structure

NLRP3-IN-12 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

NLRP3-IN-12 相关抗体

Top Publications Citing Use of Products

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

NLRP3-IN-12 is a specific NLRP3 inflammasome inhibitor. NLRP3-IN-12 reduces the release of IL-1β by targeting the NLRP3 protein, with an IC50 of 0.45 μM. NLRP3-IN-12 can be used for the research of inflammatory bowel disease[1].

IC50 & Target

NLRP3 inflammasome[1]
体外研究
(In Vitro)

NLRP3-IN-12 (化合物 6E) (0.5-2 μM; 预处理 1 h) 抑制 THP-M 细胞中 LPS/ATP 刺激的裂解 caspase-1 和 IL-1β 的表达[1]。
NLRP3-IN-12 (2 μM) 抑制 THP-M 细胞中的 GSDMD 介导的凋亡[1]。
NLRP3-IN-12 (1 μM) 在人和大鼠肝微粒体中的半衰期 (T1/2) 分别为 53.4 min 和 31.8 min[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

NLRP3-IN-12 相关抗体:

Western Blot Analysis[1]

Cell Line: THP-M cells
Concentration: 0.5, 1, 2 μM
Incubation Time: Pretreated for 1 h, then stimulated with LPS (1 μg/mL) for 4.5 h, and ATP (5 mM) for 0.5 h.
Result: Reduced the secretion of IL-1β and caspase-1.
Had no effect on the levels of NLRP3, pro-IL-1β, ASC, pro-caspase 1, p65, p-p65, IκBα, and p-IκBα.
体内研究
(In Vivo)

NLRP3-IN-12 (化合物 6E) (5-10 mg/kg; i.p. daily for 10 d) 减弱小鼠 DSS 诱导的结肠炎[1]。
NLRP3-IN-12 (20 mg/kg; i.v.) 在大鼠体内半衰期 (T1/2) 为 6.64 h，消除速率常数 (Kel) 为 0.107 h，清除率 (CL) 为 105 mL/kg/min，稳态的表观分布体积 (Vdss) 为 23.1 L/kg[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 mice were induced acute colitis by drinking 3% DSS (dextran sulfate sodium)[1]
Dosage: 5, 10 mg/kg
Administration: Intraperitoneal injection daily for 10 days in aqueous solution containing DMSO/0.5% CMC-Na/normal saline
Result: Attenuated DSS-induced weight loss, loose stools, bloody stools, shortened colons, increased disease activity index score, and lower survival rate.
分子量

518.00

Formula

C27H32ClNO7
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
参考文献

NLRP3-IN-12 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

NLRP3-IN-12NOD-like Receptor (NLR)inflammasomeIL-1βinflammatory bowel diseaseInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
NLRP3-IN-12
目录号：
HY-151952
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z